Vectra Testing, Biomarkers Help Predict Risk for CV Events in RA Patients
Myriad Genetics shared new data further demonstrating that Vectra testing and three additional biomarkers can help predict the risk of cardiovascular events in patients with rheumatoid arthritis.
Read More